Expression Pattern and Cellular Origin of Cytokines in the Normal and Toxoplasma Gondii-infected Murine Brain

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 1997 Mar 1

PMID 9060839

Citations 33

Authors

D Schluter

N Kaefer

H Hof

O D Wiestler

Affiliations

Soon will be listed here.

Abstract

In the normal brain, low levels of cytokines are observed, whereas inflammatory disorders of the central nervous system are characterized by an up-regulation of cytokine production. The cellular sources for cytokines in the central nervous system are largely undefined. In the present study, we have analyzed intracerebral cytokine production in normal and Toxoplasma gondii-infected mice using immunohistochemistry, in situ hybridization, flow cytometry of brain-derived leukocytes, and reverse transcriptase polymerase chain reaction detection in various subpopulations of inflammatory cells. In the normal brain, neurons and choroid plexus epithelia expressed interleukin (IL)-1 beta and IL-10. Microglia/macrophages produced IL-1 beta, IL-10, and tumor necrosis factor-alpha In Toxoplasma encephalitis, these cell types exhibited increased levels of the respective cytokines. In addition, microglia/macrophages showed a de novo expression of inducible nitric oxide synthase. CD4+ and CD8+ T cells, which were recruited to the brain, produced IL-2, IL-10, tumor necrosis factor-alpha, and interferon-gamma. IL-4 was exclusively detectable in CD4+ T cells, whereas CD8+ T cells showed expression of IL-1 beta. As chronic Toxoplasma encephalitis was not associated with neuronal degeneration and an up-regulation of neurotrophic factors, some cytokines may also exert neurotrophic and/or neuroprotective properties.

Citing Articles

The detection of Toxoplasma gondii ME49 infections in BALB/c mice using various techniques.

Kang H, Mao J, Kim M, Yoon K, Eom G, Chu K Parasites Hosts Dis. 2023; 61(4):418-427.

PMID: 38043537 PMC: 10693974. DOI: 10.3347/PHD.23048.

Immune response against toxoplasmosis-some recent updates RH: immune response.

Sana M, Rashid M, Rashid I, Akbar H, Gomez-Marin J, Dimier-Poisson I Int J Immunopathol Pharmacol. 2022; 36:3946320221078436.

PMID: 35227108 PMC: 8891885. DOI: 10.1177/03946320221078436.

The Polymorphic Effector GRA15 Mediates Seizure Induction by Modulating Interleukin-1 Signaling in the Brain.

Glausen T, Carrillo G, Jin R, Boyle J, Saeij J, Wohlfert E mBio. 2021; 12(3):e0133121.

PMID: 34154412 PMC: 8262954. DOI: 10.1128/mBio.01331-21.

Human Neural Stem Cell Systems to Explore Pathogen-Related Neurodevelopmental and Neurodegenerative Disorders.

Baggiani M, Dellanno M, Pistello M, Conti L, Onorati M Cells. 2020; 9(8).

PMID: 32806773 PMC: 7464299. DOI: 10.3390/cells9081893.

Presence of Toxoplasma gondii infection in brain as a potential cause of risky behavior: a report of 102 autopsy cases.

Samojlowicz D, Twarowska-Malczynska J, Borowska-Solonynko A, Poniatowski L, Sharma N, Olczak M Eur J Clin Microbiol Infect Dis. 2018; 38(2):305-317.

PMID: 30470966 PMC: 6514116. DOI: 10.1007/s10096-018-3427-z.

References

Merrill J, Jonakait G . Interactions of the nervous and immune systems in development, normal brain homeostasis, and disease. FASEB J. 1995; 9(8):611-8. DOI: 10.1096/fasebj.9.8.7768352. View

Gazzinelli R, Xu Y, Hieny S, Cheever A, Sher A . Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol. 1992; 149(1):175-80. View

Albrecht S, Hof H, Wiestler O, Schluter D . Dynamics of the intracerebral and splenic cytokine mRNA production in Toxoplasma gondii-resistant and -susceptible congenic strains of mice. Immunology. 1995; 85(3):408-18. PMC: 1383914. View

Khan I, Matsuura T, Fonseka S, Kasper L . Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice. J Immunol. 1996; 156(2):636-43. View

Hayashi S, Chan C, Gazzinelli R, Roberge F . Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis. J Immunol. 1996; 156(4):1476-81. View

Roberts C, Ferguson D, Jebbari H, Satoskar A, Bluethmann H, Alexander J . Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect Immun. 1996; 64(3):897-904. PMC: 173854. DOI: 10.1128/iai.64.3.897-904.1996. View

Bruce A, Boling W, Kindy M, Peschon J, Kraemer P, Carpenter M . Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med. 1996; 2(7):788-94. DOI: 10.1038/nm0796-788. View

Chao C, Hu S, Ehrlich L, Peterson P . Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun. 1995; 9(4):355-65. DOI: 10.1006/brbi.1995.1033. View

Sharma S, Hofflin J, Remington J . In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii. J Immunol. 1985; 135(6):4160-3. View

10.

Jones T, Bienz K, Erb P . In vitro cultivation of Toxoplasma gondii cysts in astrocytes in the presence of gamma interferon. Infect Immun. 1986; 51(1):147-56. PMC: 261078. DOI: 10.1128/iai.51.1.147-156.1986. View

11.

Ferguson D, HUTCHISON W . The host-parasite relationship of Toxoplasma gondii in the brains of chronically infected mice. Virchows Arch A Pathol Anat Histopathol. 1987; 411(1):39-43. DOI: 10.1007/BF00734512. View

12.

Farrar W, Hill J, Harel-Bellan A, Vinocour M . The immune logical brain. Immunol Rev. 1987; 100:361-78. DOI: 10.1111/j.1600-065x.1987.tb00539.x. View

13.

Suzuki Y, Orellana M, Schreiber R, Remington J . Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988; 240(4851):516-8. DOI: 10.1126/science.3128869. View

14.

Benveniste E, Sparacio S, Bethea J . Tumor necrosis factor-alpha enhances interferon-gamma-mediated class II antigen expression on astrocytes. J Neuroimmunol. 1989; 25(2-3):209-19. PMC: 7119699. DOI: 10.1016/0165-5728(89)90139-2. View

15.

Chang H, Grau G, Pechere J . Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunology. 1990; 69(1):33-7. PMC: 1385716. View

16.

Schluter D, Lohler J, Deckert M, Hof H, Schwendemann G . Toxoplasma encephalitis of immunocompetent and nude mice: immunohistochemical characterisation of Toxoplasma antigen, infiltrates and major histocompatibility complex gene products. J Neuroimmunol. 1991; 31(3):185-98. DOI: 10.1016/0165-5728(91)90040-e. View

17.

Hunter C, Roberts C, Alexander J . Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis. Eur J Immunol. 1992; 22(9):2317-22. DOI: 10.1002/eji.1830220921. View

18.

Kennedy M, Torrance D, Picha K, Mohler K . Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol. 1992; 149(7):2496-505. View

19.

Chao C, Hu S, Molitor T, Shaskan E, Peterson P . Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol. 1992; 149(8):2736-41. View

20.

Toulmond S, Vige X, Fage D, Benavides J . Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci Lett. 1992; 144(1-2):49-52. DOI: 10.1016/0304-3940(92)90713-h. View